Nebius Stock: A $27 Billion Capex Bill, a Halved Target, and the 2027 Revenue That Has to Show Up
Published on 11/19/2026 at 05:41 | Editorial boerse-global.deNebius lifted its 2026 capital spending forecast to roughly $27 billion on November 12, up from a prior range of $20 billion to $25 billion. The revision landed a day before the company published quarterly results, and together the two disclosures frame the central tension in the stock: a business expanding at breakneck speed while the bill for that expansion keeps climbing.
The third-quarter 2026 figures make the growth case plainly. Revenue reached $980.8 million, a 571% jump from the year-earlier period. Adjusted EBITDA came in at $465.8 million. Yet the continued operations still produced a net loss of $37.5 million.
Those numbers do not cancel each other out — they describe different layers of the same income statement. Anyone fixated solely on the top-line surge misses the loss; anyone reading only the loss overlooks the positive adjusted operating result. Neither metric alone settles whether Nebius is winning or losing the AI build-out.
Capital Outlay Outruns the Top Line
The spending plans give the growth debate a second dimension. Beyond sales, what counts is the capital being committed to the next stage of construction. For 2027, Nebius has held out investment of $40–45 billion, against a preliminary revenue outlook of $12–13 billion for the same year.
That pairing is not a straightforward loss calculation — capex and annual revenue are different animals. But setting them side by side shows how heavily the Nebius thesis rests on expectations stretching past any single fiscal year. The planned outlay inevitably points toward earnings that have yet to be generated.
Should investors sell immediately? Or is it worth buying Nebius?
Nor should the spending be equated with a current loss, just as a positive adjusted EBITDA does not prove the entire build-out will pay off economically. Capex describes the scale of the undertaking, not its eventual success.
A Revenue Handover Into 2027
Management attributed the shift of expected revenue into next year to delayed capacity at third-party data centers. The upshot: sales slip into the first half of 2027. Demand and booked revenue do not necessarily land in the same period, which means the build-out has to be delivered on schedule, not merely conceived at scale.
Funding for the program will come from customer prepayments and asset-backed financing, the company said alongside its results.
Brokers Trim Their Marks
Analysts moved quickly. Citigroup cut its price target on Monday to $215 from $265 while keeping a buy rating. D.A. Davidson had halved its own target on the previous Friday, from $250 to $125, maintaining a neutral stance; the firm cited data-center delays and the revised timeline for annual recurring revenue.
Two further research houses also reduced their targets that Friday, setting new marks between $200 and $245 while retaining their positive ratings.
What Would Settle the Argument
The preliminary full-year guidance deserves neither treatment as guaranteed revenue nor dismissal because of the delays. It describes the magnitude management is chasing; the quarterly report, by contrast, captures what has already been achieved. Keeping those planes separate matters more than pinning a single label on the shares.
The yardstick for Nebius is therefore clear: revenue growth, earnings quality and execution must convince together. The expansion is documented. So is the positive adjusted operating result. Turning that combination into a durable relationship between capital deployed and earnings generated is the task that remains — and the one by which the growth story should be judged.
Ad
Nebius Stock: New Analysis - 19 November
Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
